Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIa Sporozoite Challenge Study to Assess the Protective Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAP

NCT01142765 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT01142765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01142765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIa Sporozoite Challenge Study to Assess the Protective Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAP
Lead sponsor
University of Oxford
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2010
Completion date
March 31, 2011
Enrollment
52 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malaria